Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-050081)

Filing Details

Accession Number:: 0001209191-13-050081
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-10-31 20:42:54
Reporting Period:: 2013-10-29

Filing Date:: 2013-10-31
Accepted Time:: 2013-10-31 20:42:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1219503	Mark Pulido	P.o. Box 1334 Rancho Santa Fe CA 92067		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-10-29	12,750	$5.44	34,506	No	4	M	Direct
Common Stock	Disposition	2013-10-29	12,750	$25.31	21,756	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qual Stock Options	Disposition	2013-10-29	12,750	$0.00	12,750	$5.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2005-05-18	2014-05-26	No	4	M	Direct

Footnotes

This transaction was executed in multiple trades at the price of $25.31 per share, which is also the weighted average share price for this transaction. The reporting person hereby undertakes to provide upon request to the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.